Y
Yoshikazu Inoue
Researcher at Cincinnati Children's Hospital Medical Center
Publications - 273
Citations - 17662
Yoshikazu Inoue is an academic researcher from Cincinnati Children's Hospital Medical Center. The author has contributed to research in topics: Idiopathic pulmonary fibrosis & Medicine. The author has an hindex of 48, co-authored 233 publications receiving 12648 citations. Previous affiliations of Yoshikazu Inoue include Niigata University.
Papers
More filters
Journal ArticleDOI
Prognostic significance of serum cytokines during acute exacerbation of idiopathic interstitial pneumonias treated with thrombomodulin
Toru Arai,Hiroto Matsuoka,Masaki Hirose,Hiroshi Kida,Suguru Yamamoto,Yoshitaka Ogata,Masahide Mori,Kazuyoshi Hatsuda,Chikatoshi Sugimoto,Kazunobu Tachibana,Masanori Akira,Yoshikazu Inoue +11 more
TL;DR: In this paper, the authors examined the prognostic significance and pathophysiological role of serum cytokines in patients with acute exacerbation (AE) and found that higher serum levels of interleukin (IL)-2, IL7, IL-9, IL12, IL13, basic fibroblast growth factor, granulocyte-macrophage colony-stimulating factor, interferon-γ inducible protein-10, platelet-derived growth factor and regulated on activation, normal T cell expressed and secreted (RANTES) at AE were significant
Journal ArticleDOI
Pulmonary Veno-occlusive Disease: A Surgical Lung Biopsy-proven and Autopsied Case Radiologically Mimicking Hypersensitivity Pneumonitis at the Time of a Transbronchial Lung Biopsy
TL;DR: A 32-year-old woman diagnosed with PVOD via a surgical lung biopsy and autopsy whose disease showed radiological findings mimicking those of hypersensitivity pneumonitis (pneumonia) at the time of the transbronchial lungBiopsy, without obvious pulmonary hypertension on admission is reported.
Journal ArticleDOI
Effects of nintedanib on disease progression and safety in Japanese patients with progressive fibrosing interstitial lung diseases: Further subset analysis from the whole INBUILD trial.
Takashi Ogura,Takafumi Suda,Naohiko Inase,Yasuhiko Nishioka,Arata Azuma,Masaki Okamoto,Ayako Takizawa,Tomohiro Ito,Klaus B. Rohr,Yoshikazu Inoue +9 more
TL;DR: In this paper , the authors evaluated the effect of nintedanib on disease progression and assessed the safety profile over the whole trial period (i.e., a longer duration than the prior analysis) compared with placebo.
Journal ArticleDOI
Effect of nintedanib in patients with progressive fibrosing ilds and preserved lung function at baseline: further analyses of the inbuild trial
Nina Patel,Robert J. Kaner,Stefania Cerri,Yoshikazu Inoue,Heiko Mueller,Klaus B Rohr,Susanne Stowasser,Martin Kolb +7 more
Journal ArticleDOI
Lymphoplasmacytic lymphoma involving the mediastinum and the lung, followed by amyloidosis: A surgically and genetically proven case.
Yuichi Adachi,Takayuki Takimoto,Maiko Takeda,Kinnosuke Matsumoto,Naoko Takeuchi,Tomoko Kagawa,Tetsuki Sakamoto,Takahiko Kasai,Chikatoshi Sugimoto,Yasushi Inoue,Kazunobu Tachibana,Toru Arai,Yoshikazu Inoue +12 more
TL;DR: Mutation analysis, in addition to conventional histological evaluation, was useful for a precise diagnosis of lymphoplasmacytic lymphoma, involving the mediastinum and the lung, followed by amyloidosis.